Correlation Between Naturhouse Health and Concurrent Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Naturhouse Health and Concurrent Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Naturhouse Health and Concurrent Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Naturhouse Health SA and Concurrent Technologies Plc, you can compare the effects of market volatilities on Naturhouse Health and Concurrent Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Naturhouse Health with a short position of Concurrent Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Naturhouse Health and Concurrent Technologies.

Diversification Opportunities for Naturhouse Health and Concurrent Technologies

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between Naturhouse and Concurrent is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Naturhouse Health SA and Concurrent Technologies Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Concurrent Technologies and Naturhouse Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Naturhouse Health SA are associated (or correlated) with Concurrent Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Concurrent Technologies has no effect on the direction of Naturhouse Health i.e., Naturhouse Health and Concurrent Technologies go up and down completely randomly.

Pair Corralation between Naturhouse Health and Concurrent Technologies

Assuming the 90 days trading horizon Naturhouse Health SA is expected to under-perform the Concurrent Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Naturhouse Health SA is 2.37 times less risky than Concurrent Technologies. The stock trades about -0.08 of its potential returns per unit of risk. The Concurrent Technologies Plc is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  12,850  in Concurrent Technologies Plc on September 2, 2024 and sell it today you would earn a total of  1,550  from holding Concurrent Technologies Plc or generate 12.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Naturhouse Health SA  vs.  Concurrent Technologies Plc

 Performance 
       Timeline  
Naturhouse Health 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Naturhouse Health SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Concurrent Technologies 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Concurrent Technologies Plc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Concurrent Technologies exhibited solid returns over the last few months and may actually be approaching a breakup point.

Naturhouse Health and Concurrent Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Naturhouse Health and Concurrent Technologies

The main advantage of trading using opposite Naturhouse Health and Concurrent Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Naturhouse Health position performs unexpectedly, Concurrent Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Concurrent Technologies will offset losses from the drop in Concurrent Technologies' long position.
The idea behind Naturhouse Health SA and Concurrent Technologies Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA